Competing With Botox - What Is On the Horizon?
...cluding pre and post procedure pictures and a broad outline of the design of the study. He will show monthly pictures and data of patients from Phase iiib (closed out at 12 months) and IIIC (15 months into a 3-year treatment period) of the study. Reloxin: Dr. Z. Paul Lorenc, a plastic surgeon wi...Master molecular switch may prevent the spread of cancer cells to distant sites in the body
...wo forms, one called IIIb, which is expressed in epithelial cells and IIIc, which is expressed in mesenchymal cells. The protein that is made from the iiib form interacts with factors outside the cell that promote the epithelial cell behavior, that is to remain stationary. When the IIIc form is aberrantly...PET/CT may improve prognosis for patients with inflammatory breast cancer
...tends to grow more quickly and aggressively than the more common types of breast cancer. Upon diagnosis, it is already considered to be at least stage iiib (locally advanced) and even stage IV if it has spread to distant parts of the body. Because of this, IBC has been harder to successfully treat than ot...Alfacell Reports Financial Results for First Quarter of Fiscal 2009
...support its activities into the fourth quarter of fiscal year 2009. Clinical/Regulatory Update Alfacell has completed a confirmatory Phase iiib clinical trial for ONCONASE in patients suffering from unresectable malignant mesothelioma (UMM) and reached the required number of evaluable events t...Novel 4-drug combination proves safe for lung cancer treatment
...st survival benefit when Erbitux is combined with chemotherapy. Between August 2006 and September 2007, the large Phase II study enrolled 110 Stage iiib or IV non-small cell lung cancer patients, 99 of whom were able to be evaluated. Patients received six cycles of the four-drug regimen, and as mainten...Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
... infestations (2 percent). No unexpected safety concerns were identified during this study. About WELCOME The WELCOME study is a 539 patient Phase iiib multicenter 26-Week trial Evaluating the clinical benefit and tolerability of certoLizumab pegol induCtiOn and Maintenance in patients suffering from ...Gene Signature May Predict Recurrence of Lung Cancer
... regimens starting as little as one month after surgery. Twenty individuals newly diagnosed with and who had undergone surgery for Stage I to Stage iiib lung cancer were asked to exercise three times a week for one hour at a time on stationary bikes. After 14 weeks, participants reported being less tir...Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Trial Will Build on Pivotal Phase III Study for the Treatment of Advanced Prostate Cancer PARSIPPANY, N.J., April 27 /PRNewswire/ -- Ferring Pharmaceuticals announced today the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (G...Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
WOODCLIFF LAKE, N.J., May 29 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX ) today announced that its development partner, Alfacell Corporation (Nasdaq: ACEL ) reported that the preliminary statistical a...Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
- Company to Host Conference Call/Webcast at 8:30 a.m. EDT on May 29 - SOMERSET, N.J., May 28 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL ) today announced that the preliminary statistical analysis of data from its confirmatory Phase IIIb clinical trial of its lead compound,...Alfacell Provides Shareholder Update
...and our valuable compounds realize their full potential. As you are aware, we did not meet our primary endpoint of overall survival in our Phase iiib clinical trial in patients suffering from unresectable malignant mesothelioma (UMM). We did however; achieve statistical significance with a subgroup ...Alfacell Provides ONCONASE(R) NDA Submission Update
... meeting. As the company has previously reported, the results of the preliminary statistical analysis of the data from the confirmatory Phase iiib clinical trial for ONCONASE in patients suffering from UMM did not meet statistical significance for the primary endpoint of survival in UMM. However...NovaRx Appoints Industry Veteran as President and COO
...lized in that Phase II trial to treat advanced stage NSCLC patients (stages iiib and IV) who had received zero to five prior chemotherapies, demonstrated a ...vival. Typical two year survival for stage IV patients is 5% and for stage iiib is 10% on average. Currently, 59% of the patients who received Lucanix(R) ...Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring
Features:... Corrects for the valvular insufficiency associated with Type iiib mitral regurgitation. Decreased anteroposterior (AP) distance increases leaflet coaptation. Asymmetric 3-D reduced P2-P3 curvature design comp...Living view in animals shows how cells decide to make proteins
...the scientists could track whether intronic silencers were chopping out the iiib exon -- and if so, in which tissues and organs -- or whether other types of...ocesses," Bonano said. For example, a cell’s decision to include exon iiib is critical because the exon’s presence or absence determines which variant...Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
...ued Stimuvax therapy after 2.4 and 5.8 years, respectively, and were without evidence of disease progression. Nine of the 10 living patients had stage iiib NSCLC upon entry to the trial, while one had stage IV disease. Six of the 10 living patients had a complete response to their first-line chemotherapy ...BioVex Raises $40 Million in First Close of Series F Financing
...se III study will also enroll previously treated patients with unresectable Stage IIIc and Stage IV disease using OncoVEX GM-CSF as monotherapy. Stage iiib patients will also be eligible. The primary efficacy endpoint will also be response rate-based; the primary objective being to demonstrate a statistic...Alfacell Provides ONCONASE(R) NDA Submission Update
...itting a NDA. As the company has previously reported, the results of the preliminary statistical analysis of the data from the confirmatory Phase iiib clinical trial for ONCONASE in patients suffering from UMM did not meet statistical significance for the primary endpoint of survival in UMM. However...Alfacell Receives Going Concern Audit Opinion
...nabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to a recently completed Phase iiib study in malignant mesothelioma, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visi...Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
...luding the U.S. license agreement with Strativa and completion of the Phase iiib clinical trial for ONCONASE in UMM. In fiscal 2009, we plan to complete the... other life-threatening diseases. In addition to a recently completed Phase iiib study in malignant mesothelioma, Alfacell is currently planning for Phase I...NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
...t approximately 90 clinical sites in the U.S., Canada, India, and Europe. In a Phase II clinical trial, two-year survival among patients with stages iiib and IV disease who received Lucanix(R) was significantly longer than that of individuals being treated with the current standard of care. A second, in...Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
...nabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to a recently completed Phase iiib study in malignant mesothelioma, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visi...